StonvexLoading…
StonvexCore line items from EYPT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $428.40K | $696.00K | $31.37M | $30.75M | $29.79M |
Operating Income | Not available | $-87.23M | $-243.43M | $-173.09M | $-111.06M |
Net Income | Not available | $-84.83M | $-231.96M | $-164.35M | $-104.62M |
EPS (Diluted) | $-0.96 | $-0.99 | $-3.17 | $-2.35 | $-1.50 |
Total Assets | Not available | $288.22M | $364.00M | $251.69M | $301.15M |
Total Liabilities | Not available | $57.74M | $57.88M | $51.51M | $55.14M |
Cash & Equivalents | Not available | $77.71M | $101.82M | $74.58M | $71.14M |
Free Cash Flow OCF − CapEx | Not available | $-81.55M | $-243.39M | $-177.36M | $-117.20M |
Shares Outstanding | Not available | 83.45M | 82.83M | 69.57M | 68.89M |